145 related articles for article (PubMed ID: 23440398)
1. Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris.
Chen T; Guo ZP; Li L; Wang L; Jia RZ; Cao N; Qin S; Li MM
Arch Dermatol Res; 2013 Apr; 305(3):263-7. PubMed ID: 23440398
[TBL] [Abstract][Full Text] [Related]
2. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
[TBL] [Abstract][Full Text] [Related]
3. High mobility group box 1 is increased in the sera of psoriatic patients with disease progression.
Bergmann C; Strohbuecker L; Lotfi R; Sucker A; Joosten I; Koenen H; Körber A
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):435-41. PubMed ID: 26834049
[TBL] [Abstract][Full Text] [Related]
4. Increased serum HMGB1 levels in patients with Henoch-Schönlein purpura.
Chen T; Guo ZP; Wang WJ; Qin S; Cao N; Li MM
Exp Dermatol; 2014 Jun; 23(6):419-23. PubMed ID: 24758390
[TBL] [Abstract][Full Text] [Related]
5. TNF-like ligand 1A is associated with the pathogenesis of psoriasis vulgaris and contributes to IL-17 production in PBMCs.
Li L; Fu L; Lu Y; Wang W; Liu H; Li F; Chen T
Arch Dermatol Res; 2014 Dec; 306(10):927-32. PubMed ID: 25200589
[TBL] [Abstract][Full Text] [Related]
6. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
[TBL] [Abstract][Full Text] [Related]
7. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
8. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
[TBL] [Abstract][Full Text] [Related]
9. Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis.
Kim HO; Cho SI; Chung BY; Ahn HK; Park CW; Lee CH
Clin Exp Dermatol; 2012 Jul; 37(5):521-6. PubMed ID: 22680616
[TBL] [Abstract][Full Text] [Related]
10. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.
Gambichler T; Skrygan M; Tomi NS; Othlinghaus N; Brockmeyer NH; Altmeyer P; Kreuter A
Int Arch Allergy Immunol; 2008; 147(1):17-24. PubMed ID: 18446049
[TBL] [Abstract][Full Text] [Related]
11. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
12. Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris.
Strohbuecker L; Koenen H; van Rijssen E; van Cranenbroek B; Fasse E; Joosten I; Körber A; Bergmann C
Psoriasis (Auckl); 2019; 9():7-17. PubMed ID: 30859087
[TBL] [Abstract][Full Text] [Related]
13. Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis.
Kou K; Okawa T; Yamaguchi Y; Ono J; Inoue Y; Kohno M; Matsukura S; Kambara T; Ohta S; Izuhara K; Aihara M
Br J Dermatol; 2014 Aug; 171(2):283-91. PubMed ID: 24601864
[TBL] [Abstract][Full Text] [Related]
14. Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis.
Yawalkar N; Schmid S; Braathen LR; Pichler WJ
Br J Dermatol; 2001 Jun; 144(6):1133-9. PubMed ID: 11422032
[TBL] [Abstract][Full Text] [Related]
15. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
[TBL] [Abstract][Full Text] [Related]
16. Expression of death receptor 3 (DR3) on peripheral blood mononuclear cells of patients with psoriasis vulgaris.
Li L; Lu Y; Fu L; Zhou P; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Zhou Y; Chen T
Postgrad Med J; 2018 Oct; 94(1116):551-555. PubMed ID: 30341229
[TBL] [Abstract][Full Text] [Related]
17. Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease.
Kurtovic NO; Halilovic EK
Med Arch; 2018 Dec; 72(6):410-413. PubMed ID: 30814771
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of interleukin 33 in patients with atopic dermatitis.
Tamagawa-Mineoka R; Okuzawa Y; Masuda K; Katoh N
J Am Acad Dermatol; 2014 May; 70(5):882-8. PubMed ID: 24569114
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein D in atopic dermatitis and psoriasis.
Hohwy T; Otkjaer K; Madsen J; Søerensen G; Nielsen O; Vestergaard C; Steiniche T; Holmskov U; Lomholt H
Exp Dermatol; 2006 Mar; 15(3):168-74. PubMed ID: 16480424
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
